Connect with us

Media OutReach

Immuno Cure Kicks off Phase I Clinical Study of Therapeutic DNA Vaccine for HIV in Hong Kong

Published

on

HONG KONG SAR – Media OutReach Newswire – 26 January 2026 – Immuno Cure BioTech (“Immuno Cure“) is pleased to announce today the initiation of a Phase I clinical study of ICVAX, a therapeutic DNA vaccine for HIV, in collaboration with the Faculty of Medicine of The Chinese University of Hong Kong (“CUMedicine“), the AIDS Institute of The University of Hong Kong (“HKU AIDS Institute“), and Greater Bay Area International Clinical Trials Center (“BAY TRIAL“).

As a lead candidate under Immuno Cure’s patented “PD-1-Enhanced DNA Vaccine Technology Platform”, ICVAX aims to achieve sustained, immune-mediated HIV-1 virological control without the need of antiretroviral therapy. Following the successful first-in-human ICVAX Phase I clinical trial in Shenzhen that showed exceptional safety and immunogenicity profiles, this clinical study will explore the safety and immunogenicity of ICVAX in HIV-infected volunteers in Hong Kong, to be administered by three distinct delivery systems. This comparative approach will provide essential data on the optimal delivery method for ICVAX, and hence potentially identifying the most effective, patient-friendly and scalable option for enhancing immunotherapeutic responses in people living with HIV.

The clinical study will be conducted at Prince of Wales Hospital and will be led by Dr Grace LUI, Head of the Division of Infectious Diseases at CUHK Medicine’s Department of Medicine and Therapeutics, as the Principal Investigator. This is a randomized clinical study to evaluate the immunogenicity and safety of ICVAX in a total of 22 HIV-infected volunteers using three delivery systems: Teresa-EPT-1 electroporation device, PharmaJet’s Tropis, a WHO pre-qualified needle-free injection system, and PapiVax’s TriGrid EP device.

This study has been granted ΗΚ$4.2 million funding under the Public Sector Trial Scheme of the Innovation and Technology Fund of the HKSAR Government (project reference number: UTT/002/23GM). Professor Zhiwei CHEN, Director of the HKU AIDS Institute and Principal Scientific Advisor of Immuno Cure, serves as the Project Coordinator for this funding. This study is also partially supported by Theme-based Research Scheme (TRS) of the Research Grants Council under the University Grants Committee of the Education Bureau (project reference number: T11-702/24-N).

“This Phase I clinical study is an important landmark, being the first evaluation of ICVAX in Hong Kong volunteers and incorporating multiple innovative delivery technologies,” said Dr Grace LUI. “By testing these devices, we aim to optimize safety, immunogenicity, and patient experience for this promising HIV therapeutic DNA vaccine candidate.”

“ICVAX is built on the innovative PD-1-Enhanced DNA vaccine technology invented and developed locally at the HKU,” said Professor Zhiwei CHEN. “This study will help optimize delivery of ICVAX, paving the way for broader international deployment.”

“The launch of this clinical study is a major milestone of vaccine development for Immuno Cure,” said Dr Xia JIN, CEO of Immuno Cure. “By testing ICVAX for the first time in Hong Kong and comparing three innovative delivery devices this study not only advances our understanding of the performance of our DNA medicines, but also significantly supports the global commercialization of ICVAX and our other DNA medicines. Immuno Cure is committed to leading innovation in immunotherapy to combat infectious diseases and cancers.”

Hashtag: #ImmunoCure

The issuer is solely responsible for the content of this announcement.

About Immuno Cure

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA Vaccine Platform and Anti-Δ42PD1 Antibody Platform

To learn more about Immuno Cure, please visit .

About CUHK Medicine

Established in 1981, CU Medicine has achieved international recognition in teaching, research, and clinical practice and is the youngest medical school ranked among the world’s top 25 in many global rankings. In the “Best Global Universities Subject Rankings 2025-26” by U.S. News and World Report, its “Gastroenterology and Hepatology”, “Endocrinology and Metabolism” and “Clinical Medicine” programmes rank 1st in Asia, while Gastroenterology and Hepatology claims 2nd globally.

The Faculty comprises 14 clinical departments and five schools, delivering a world-class environment for teaching and research with a strong emphasis on interdisciplinary, interprofessional, and international collaboration. To date, it has cultivated over 6,000 medical graduates who are making an impact across local and global healthcare systems. The Faculty is dedicated to driving innovation by translating groundbreaking research into real-world clinical applications. Its contributions have reshaped medicine — evidenced by the filing of 3,000 patents, strategic patent acquisitions, and the establishment of more than 20 start-ups. Its pioneering research has not only rewritten international clinical guidelines but also revolutionised the prevention, diagnosis, and treatment of numerous diseases.

To learn more about CU Medicine, please visit .

About HKU AIDS Institute

HKU AIDS Institute was established in November 2007 to take HKU in a new strategic direction in fighting this global epidemic and help to make it a leader in the region in AIDS research, education and prevention. Scientists at the AIDS Institute are fully committed to conducting basic and applied research that facilitates the understanding of AIDS pathogenesis and the development of effective AIDS vaccines. Currently, the Institute is leading the Hong Kong Theme-based Research Scheme entitled “Potentiating Host Immunity for HIV-1 Functional Cure”.

To learn more about HKU and AIDS Institute of HKU, please visit and .

About BAY TRIAL

BAY TRIAL is a key initiative in implementing the “Notice of the State Council on Issuing the Development Plan for the Shenzhen Park of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone” (State Council [2023] No. 12). It serves as strong support for Shenzhen’s development as an international science and technology innovation centre and for promoting the high-quality development of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). Located in the Hetao Shenzhen-Hong Kong Cooperation Zone, BAY TRIAL leverages the zone’s unique geographical and policy advantages to integrate clinical trial innovation resources across the GBA, deepen Shenzhen-Hong Kong science and technology collaboration, and establish a one-stop clinical trial platform.

To learn more about BAY TRIAL, please visit:

Media OutReach

Sun Group debuts at SITF 2026 with exclusive Phu Quoc flight deals and a fresh vision for Vietnam tourism

Published

on

SEOUL, SOUTH KOREA – Media OutReach Newswire – 6 June 2026 – Making its first-ever appearance at the Seoul International Travel Fair (SITF) 2026, one of South Korea’s largest international travel fairs, held from June 4–7, Sun Group has delivered a meaningful message: “Visit Vietnam: Beloved Destinations – Extraordinary Experiences.” The group has showcased iconic destinations including Da Nang, Phu Quoc, Sa Pa, and Ha Long, while telling the story of a Vietnam that is constantly innovating to create unique experiences for global travelers.

The Sun Group booth attracts a large number of visitors with its interactive activities, destination ecosystem, and promotions.

A special highlight is Sun Group’s unveiling of its new development vision for Phu Quoc in the lead‑up to APEC 2027, presented directly to Korean partners and visitors.

From the first day of the fair, Sun Group’s booth has welcomed a steady stream of visitors. Throughout the four-day event, the booth has organized B2B and B2C networking activities, customer consultations, and introductions to tourism, resort, and aviation products. Interactive programs, including mini-games, souvenir giveaways, and tailored offers for the Korean market, have kept the atmosphere lively for hours, with a continuous flow of engaged visitors.

During SITF (June 4–7), travelers have the opportunity to receive a 20% discount on the base fare when booking Sun PhuQuoc Airways tickets via the airline’s website or app. The offer applies to the Korean market for one‑way or round‑trip journeys from Korea to Phu Quoc. Limited to 200 Economy Class discount codes, it is valid for flights from June 15 to October 24, 2026 (excluding peak periods as defined by the airline).

Visitors also have the chance to win attractive prizes through booth activities, including free round‑trip air tickets on the Seoul–Phu Quoc route (ICN–PQC) and resort vouchers at hotels within Sun Group’s ecosystem.

By combining destination promotion with airline incentives, Sun Group aims to further encourage South Korean tourists to choose Vietnam for their upcoming holidays, especially Phu Quoc, which is entering a new era of large‑scale investments in projects, products, and experiences all aimed at APEC 2027.

Hashtag: #SunGroup

The issuer is solely responsible for the content of this announcement.

About Sun Group

Vietnam’s leading private economic group, Sun Group operates an integrated ecosystem spanning tourism, entertainment, hospitality, real estate, infrastructure, and aviation. Guided by the mission “Enhancing the beauty of the lands,” the Group shapes iconic destinations nationwide through its Sun World entertainment brand. In the aviation sector, Sun Group develops a hub-and-spoke model anchored by Phu Quoc, driven by strategic airport investments and Sun PhuQuoc Airways.

Continue Reading

Media OutReach

Technology + Scenario + Supply Chain = A New Benchmark for Regional Zero-Carbon Smart Transportation

Published

on

Wing Kai New Energy X QIJI Energy X C&D Hi-Tech

HONG KONG SAR – Media OutReach Newswire – 5 June 2026 – The 19th (2026) International Photovoltaic Power Generation and Smart Energy Exhibition & Conference (SNEC 2026) was grandly held from June 3 to 5, 2026, at the National Exhibition and Convention Center (Shanghai). Attracting over 3,000 exhibitors from 95 countries worldwide, the event stands as the largest and most influential professional grand gathering for the photovoltaic and energy storage sectors across Asia and globally.

During the exhibition, Mr. Yiu Wang Lee, Chairman of the Board of Wing Lee Development Construction Holdings Limited (“Wing Lee” or the “Group”, stock code: 9639.HK); Mr. Cai Huihui, General Manager of Wing Kai New Energy Technology Co., Limited (“Wing Kai New Energy”); Mr. Wang Yi, Key Account Manager of QIJI Energy; Mr. Xu Jun, Overseas Energy Storage Commercial Director of Contemporary Amperex Technology Co., Limited (CATL); and Mr. You Yuxian, ASEAN Regional Energy Storage Sales Director of CATL, jointly visited the exhibition booth of C&D Hi-Tech. The delegation engaged in in-depth discussions with the team led by General Manager Mr. Zhan Shengli, focusing on battery swapping station projects in Hong Kong and Southeast Asia. By integrating multi-party resources, the teams successfully finalized and signed a Strategic Cooperation Agreement.

Through this signing, the three parties will join forces to address and resolve the industry pain points of overseas markets regarding regulatory compliance, engineering infrastructure, and supply chain coordination. The collaboration represents a deep integration of QIJI Energy’s cutting-edge battery swapping solutions, Wing Kai New Energy’s localized infrastructure and operational capabilities across Hong Kong and Shenzhen, and C&D Hi-Tech’s robust global resource allocation strengths. Moving from single-project development to an ecosystem of mutual win-win, this partnership will significantly enhance the delivery efficiency of green energy across Hong Kong, Macau, and the Southeast Asian region, setting a brand-new benchmark for regional zero-carbon smart transportation.

As a subsidiary of Wing Lee, Wing Kai New Energy has been rooted in Hong Kong since its inception while radiating its presence globally, deeply cultivating sustainable clean energy solutions. Addressing the acute pain points in the Greater Bay Area and Southeast Asian markets, where rapid fluctuations in energy prices have led to surging cost pressures for logistics distribution enterprises, Wing Kai New Energy will focus on urban distribution logistics battery swapping businesses in the future. The company plans to integrate site resources, infrastructure, and operations to fill the gap in regional infrastructure. We firmly believe that this cooperation will effectively bridge the cross-border green energy eco-link, accelerate the construction of a green energy service network, and contribute solidly to the realization of the “dual carbon” goals. Meanwhile, we sincerely invite more partners to join the Zero-Carbon Smart Alliance to jointly advance sustainable development.

Hashtag: #WingLee

The issuer is solely responsible for the content of this announcement.

About Wing Lee Development Construction Holdings Limited

Deeply rooted in Hong Kong, Wing Lee is an established contractor engaged in civil engineering, electrical and mechanical engineering, and new energy businesses, and has participated in various large-scale landmark projects in Hong Kong. The Group’s civil engineering business specialized in site formation waterworks as well as road and drainage works, while its electrical and mechanical engineering business specializes in power system-related projects and emergency maintenance works. In recent years, the Group has actively expanded into the new energy sector, undertaking solar photovoltaic projects, distributing various electric commercial vehicles and electric construction machinery, and engaging in the construction and subsequent maintenance of charging piles, battery swapping, recycling, and energy storage businesses. In 2025, Wing Lee Construction, together with SANY Group Co., Ltd. and CATL, among other industry giants, founded the “Zero-Carbon Smart Alliance” to develop full-industry-chain solutions for photovoltaics, energy storage, charging and battery swapping, and smart applications in green transportation.

Continue Reading

Media OutReach

Hong Kong wraps up successful mission to deepen ties with Central Asia

Published

on

HONG KONG SAR – Media OutReach Newswire – 5 June 2026 – A large high-level business delegation led by John Lee, Chief Executive of the Hong Kong Special Administrative Region (HKSAR), today (June 5) wrapped up its five-day visit to Kazakhstan and Uzbekistan respectively, achieving fruitful results of strengthening bilateral relations and deepening ties with Central Asia.

The delegation of over 70 business and institutional leaders from Hong Kong and the Chinese Mainland is the largest and most diverse overseas mission led by the current term of the HKSAR Government so far.

Hong Kong SAR’s Chief Executive, John Lee (fifth right) and the Advisor to the President of Uzbekistan on Strategic Development, Sardor Umurzakov (fourth right) witness the exchange of memoranda of understanding and co-operation agreements between government departments, enterprises and organisations from Hong Kong and Uzbekistan.

Speaking to the media in Uzbekistan yesterday (June 4), Mr Lee set out the three main objectives of the visit: further explore emerging markets and lay the foundation for long-term economic and trade development; strengthen government-to-government (G2G) relationships and promote closer bilateral co-operation; and build a “hub-to-hub” model of co-operation.

He said the visit had been successful, yielding achievements in eight areas, including:

  • Establishing high-level contacts and ties between the HKSAR Government and the Governments of Kazakhstan and Uzbekistan, and reaching consensus on co-operation in multiple areas;
  • A total of 96 co-operation agreements and memoranda of understanding (MoUs) were reached during the visit (61 with Kazakhstan, 35 with Uzbekistan), involving specific amounts exceeding US$1.65 billion in total;
  • The governments agreed to commence bilateral discussions on agreements in various areas;
  • Deepening project matching and research collaboration between Hong Kong and Central Asian region in areas including finance, innovation and technology (I&T), and aviation;
  • Demonstrating Hong Kong’s effective role as a platform for going global and achieving substantial results, with Hong Kong and Mainland enterprises joining forces in tapping new markets and bringing synergistic advantages into full play;
  • Facilitating more convenient people-to-people exchanges by promoting direct flights, aviation and transport co-operation, and extensions to the mutual visa-free period;
  • Promoting exchanges in education, talent and culture to further deepen people-to-people bonds; and
  • Advancing a hub-to-hub co-operation model to open up broader room for co-operation between Hong Kong and the Central Asian region.

image-1.jpeg

While in Tashkent (June 3-5), Mr Lee met with local leaders, government officials and business representatives to deepen co-operation between Hong Kong and Uzbekistan in areas including trade, investment, finance, I&T, and people-to-people exchanges.

Mr Lee held meetings with the President of Uzbekistan, Shavkat Miromonovich Mirziyoyev, his Advisor on Strategic Development, Sardor Umurzakov, the Prime Minister, Abdulla Nigmatovich Aripov, as well as the Deputy Prime Minister, Jamshid Khodjayev, to exchange views on furthering mutual co-operation.

Mr Lee highlighted that under the “one country, two systems” principle, Hong Kong enjoys both the China advantage and the global advantage. He said that Hong Kong would continue to play its roles as a “super connector” and a “super value-adder” to further deepen co-operation and exchanges with Uzbekistan on various fronts in line with Uzbekistan’s goal of achieving high-quality development.

Hong Kong SAR's Chief Executive, John Lee (left) meets with the President of Uzbekistan, Shavkat Miromonovich Mirziyoyev.
Hong Kong SAR’s Chief Executive, John Lee (left) meets with the President of Uzbekistan, Shavkat Miromonovich Mirziyoyev.

Earlier (June 3), Mr Lee met with the Minister of Foreign Affairs of Uzbekistan, Bakhtiyor Saidov, after which they jointly witnessed an exchange of notes between the two places on a mutual visa-free arrangement, which would allow a visa-free period of 30 days for visitors from both sides.

“Moreover, we are glad to have initialed the Air Services Agreement with Uzbekistan, and look forward to launching direct passenger flights between the two places soon,” Mr Lee said, during a high-level business dinner (June 4). The Chief Executive pointed out that Hong Kong and Uzbekistan are important trade and investment gateways to their respective regions – the Asia-Pacific and Central Asia.

“It helps that we are all believers in the Belt and Road (B&R) Initiative, a modern expression of the ancient Silk Road spirit,” Mr Lee said. “Today, China is Uzbekistan’s largest trading partner, and the two countries work closely on major infrastructure and connectivity projects that are revitalising the Silk Road. Hong Kong is a pivotal player in the B&R Initiative, thanks to our world-class professional and financial services expertise.”

The delegation also toured the IT Park Uzbekistan and the Center for Islamic Civilization before concluding its visit in Tashkent.

Hashtag: #HongKong #BrandHongKong #CentralAsia #Kazakhstan #Uzbekistan





The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending